NFKB1 and acute respiratory distress syndrome: The researchers found that in LPS-treated human AECs, PCB2 inhibited the activation of the NF-κB and NLRP3 inflammasomes, suggesting that it may have therapeutic potential for acute lung injury (ALI) [44].